Serum pentosidine levels are associated with reduced eGFR, including in individuals with preserved renal function: a cross-sectional analysis from the Fukuoka Epidemiological Study of Atherosclerosis

Abstract Background Advanced glycation end products, particularly pentosidine, are implicated in age-related diseases and are influenced by renal function and glycemic status. Although elevated pentosidine levels are well documented in individuals with chronic kidney disease (CKD) stage G3b or highe...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Kenji Ito, Koji Takahashi, Kazuhiro Tada, Toshiki Maeda, Yukiko Shinohara, Yori Inoue, Atsushi Satoh, Makiko Abe, Tetsuhiko Yasuno, Hisatomi Arima, Kosuke Masutani
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2026-05-01
Edice:	BMC Nephrology
Témata:	Advanced glycation end products Pentosidine Chronic kidney disease
On-line přístup:	https://doi.org/10.1186/s12882-026-05022-9
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!